泰比棣医药科技

TBD (Shanghai) Pharma Tech is a specialized biotechnology company and contract research organization (CRO) focused on small molecule drug discovery and development. Headquartered in Shanghai's Zhangjiang Hi-Tech Park, the company leverages its expertise in medicinal chemistry to support global pharmaceutical and biotech partners. A core strength of the company is its advanced Proteolysis-Targeting Chimera (PROTAC) platform, which facilitates the discovery and optimization of protein degraders. TBD provides a comprehensive suite of services including lead optimization, custom synthesis, and process chemistry for complex molecules. By integrating innovative chemical biology with traditional drug discovery, the company aims to accelerate the development of novel therapeutics for oncology and immunology.